Table 3.
Clinical trials of CQ and HCQ for the treatment of viral disease other than COVID-19
| Viral disease | NCT number | Trial phase | Viral disease | NCT number | Trial phase | Viral disease | NCT number | Trial phase |
|---|---|---|---|---|---|---|---|---|
| Intervention: CQ | Intervention: HCQ | |||||||
| AIDS | NCT00972725 | II | HIV | NCT00308620 | II/III | Hepatitis C | NCT01833845 | I/II |
| Autoimmune hepatitis | NCT01980745 | IV | NCT00132535 | N/A | HIV | NCT01232660 | I | |
| NCT02463331 | IV | NCT00819390 | II | NCT01067417 | II | |||
| Chikungunya | NCT00391313 | III | Influenza | NCT01078779 | II | NCT02475915 | I/II | |
| Dengue | NCT00849602 | I/II | Rabies | NCT02564471 | IV | |||
| Hepatitis C virus | NCT02058173 | IV | ||||||